- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03084159
Multi-disciplinary Participatory Design of a Process to Deliver a CKD Diagnosis in Primary Care (EPIK)
This study will use an adapted education worksheet to support patient-centered chronic kidney disease (CKD) communication, shared decision making, and patient engagement and will test its impact on intermediate patient modifiable characteristics in a primary care practice with patients who have pre-dialysis CKD.
The study team will enroll up to 100 patients with chronic kidney disease (CKD) from a primary care clinic to start. Patients will receive the intervention, which consists of the physicians using the education worksheet during appointments with patients, and patients and providers will complete surveys about its use and to measure impact on knowledge and other areas related to patient outcomes.
Once initial user testing is complete, the study team plans to submit an amendment to expand on this trial and incorporate comparison sites. This will be submitted and receive IRB approval prior to participant involvement.
The study hypothesis is that patients who receive the intervention will have greater knowledge about their CKD diagnosis, higher satisfaction with provider communication, and higher scores related to managing CKD to keep themselves healthy compared to control populations.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Amendment on 12/2018: The enrollment numbers were updated to include the control group.
Clarification 9/2021: After initial feasibility was assessed, the initial site was used additionally to enroll for the "second arm", rather than a new site as originally intended. A second site was then used for the control population.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Michigan
-
Canton, Michigan, États-Unis, 48187
- Canton Health Center
-
Northville, Michigan, États-Unis, 48168
- Northville Health Center
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- 18 years old or older
- Have an estimated glomerular filtration rate (eGFR) of less than 60 ml/min/1.73 m2
- Able to read and understand English without an interpreter
- Diagnosed with chronic kidney disease on record
Exclusion Criteria:
- Patients with renal transplant or on dialysis
- Patients who have documented or provider known cognitive impairment or vision impairment that will prohibit meaningful interaction with education activation worksheet
- Patients who are not aware of their CKD diagnosis
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Non randomisé
- Modèle interventionnel: Affectation factorielle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: Participatory design and intervention
Patients in this arm will receive the intervention of using an education worksheet during their appointment with their provider.
They will be asked to complete post intervention surveys (for feasibility and feedback prior to actual trial enrollment).
Providers and staff at this site have been involved in the design of the intervention process, to make it streamlined and efficient for application in practice.
|
Patients who screen positive for CKD and give written informed consent to be a part of the study will have their chart flagged for the medical assistant and provider to give the education worksheet intervention.
The education worksheet has been developed to be used as an electronic tool within the Electronic Medical Record.
The provider will review it with the patient during the visit.
A paper copy will print out for the patient at the end of the visit.
Autres noms:
|
Expérimental: Intervention Only
This arm include new patients at the initial site that also received the intervention of using an education worksheet during their appointment and filled out post intervention surveys.
Some of these providers/staff were not involved in the initial design of the intervention.
|
Patients who screen positive for CKD and give written informed consent to be a part of the study will have their chart flagged for the medical assistant and provider to give the education worksheet intervention.
The education worksheet has been developed to be used as an electronic tool within the Electronic Medical Record.
The provider will review it with the patient during the visit.
A paper copy will print out for the patient at the end of the visit.
Autres noms:
|
Aucune intervention: Usual Care
A second site included usual care, which did not include the intervention.
Participants were given post visit surveys similar to those in the two other study / intervention arms.
This site served as a usual care comparison.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Level of objective understanding of CKD as measured by the Kidney Knowledge Survey (KiKS)
Délai: Length of doctor's appointment, e.g., 1-2 hours
|
This will measure objective kidney disease knowledge, based on a score of 0-100, where 0 means poor level of kidney knowledge, and 100 means good level of kidney knowledge.
The KiKS was developed by Dr. Wright.
|
Length of doctor's appointment, e.g., 1-2 hours
|
Level of perceived understanding of CKD as measured by the Perceived Kidney Knowledge Survey (PiKS)
Délai: Length of doctor's appointment, e.g., 1-2 hours
|
This will measure subjective kidney knowledge.
Score range is 1-4, where 1 is low level of perceived kidney knowledge, and 4 is high level of perceived kidney knowledge.
The PiKS was developed by Dr. Wright.
|
Length of doctor's appointment, e.g., 1-2 hours
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Level of positive perception of patient-provider communication as measured by the Patient Communication Assessment Tool (CAT)
Délai: Length of doctor's appointment, e.g., 1-2 hours
|
This assesses the quality of physician to patient and physician's staff to patient communication.
Score range is 1-5, where 1 means negative perception of communication and 5 means positive perception of communication.
|
Length of doctor's appointment, e.g., 1-2 hours
|
Level of mental anxiety/stress related to condition as measured by the adapted NDBCSS scale
Délai: Length of doctor's appointment, e.g., 1-2 hours
|
The 19-item NDBCSS (Newly Diagnosed Breast Cancer Stress Scale) is adapted to form the 21-item scale in the patient survey to measure stress associated with CKD.
The score range is 1-4, where 1 means high level of stress associated with CKD and 4 means low level of stress associated with CKD.
|
Length of doctor's appointment, e.g., 1-2 hours
|
Level of energy/fatigue and emotional well-being as measured by the SF-36 mental health component
Délai: 4 weeks
|
The SF-36 mental health component is a 9-item scale that measures energy/fatigue and emotional well-being in the past 4 weeks.Score range is 0-100, where 0 means poor emotional well-being and low energy and 100 means good emotional well-being and high energy.
|
4 weeks
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Level of positive assessment of care as measured by the Patient Assessment of Care for Chronic Conditions (PACIC) scale
Délai: 6 months
|
This is a 11-item scale evaluating patient assessment of the quality of care that patients received in the past 6 months.
Score range is 1-5, where 1 means poor assessment of quality of care and 5 means good assessment of quality of care.
|
6 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Julie Wright-Nunes, MD, MPH, University of Michigan
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- HUM00118819
- 4K23DK097183-04 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Maladie rénale chronique
-
PfizerComplétéLeucémie, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) PositifFrance, États-Unis, Canada, Espagne, Tchéquie, Singapour, Thaïlande, Danemark, Norvège, Corée, République de, Finlande, Hongrie, Suède, Pays-Bas, Italie, Allemagne, Ukraine, Afrique du Sud, Taïwan, Australie, Belgique, Israël, Mexique, Pologn... et plus
Essais cliniques sur Education worksheet
-
Universidad San SebastiánUniversidad de Valparaiso; Fondo de Fomento al Desarrollo Científico y Tecnológico...RecrutementGain de poids gestationnel | Obésité maternelleChili
-
Oregon Research InstituteComplétéTrouble lié à l'utilisation de substances | DélinquanceÉtats-Unis